Skip to main content
. 2019 Mar 15;42:145–156. doi: 10.1016/j.ebiom.2019.03.010

Table 5.

Anti-PRIMVAC IgG titers (1/X).

0.9% NaCl
PRIMVAC
PRIMVAC + Alhydrogel®
PRIMVAC + GLA-SE
M F M F M F M F
Pre-treatment 20 20 0 0 0 30 0 0
Day 45 160 440 158,720 204,800 634,880 ≥819,200 634,880 ≥819,200
Day 65 70 110 174,080 296,960 ≥819,200 ≥819,200 ≥819,200 ≥819,200